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Immunoblot analysis of convalescent-phase sera of experimentally infected chimpanzees or monoclonal
antibodies (MAbs) specific to the 90- and 40-kDa proteins of Mycoplasma pneunoniae indicated that both
proteins were present in cytadsorbing, pathogenic strains PI-1428, M129, and FH but absent in noncytad-
sorbing, nonpathogenic strain M129-B176. Adsorption of convalescent-phase chimpanzee sera with virulent
strain PI-1428 removed reactivity, whereas adsorption with avirulent strain M129-B176 did not remove
reactivity to these two proteins. By using proteolysis and specific MAbs, we demonstrated that the 90- and
40-kDa proteins were surface exposed. Immunoelectron microscopy employing specific MAbs showed that the
90-kDa protein is localized on the terminal tip attachment apparatus. However, the MAb specific for the
40-kDa protein failed to indicate a similar localization. Nevertheless, these data, taken together, indicate that
the immunodominant 90- and 40-kDa proteins are surface exposed, are localized on the terminal tip apparatus,
and might be involved in the attachment mechanism.
The ability of Mycoplasma pneumoniae to attach is a
prerequisite for colonization of the respiratory mucosal
epithelium and subsequent induction of disease in humans
and animals (16, 17, 24, 42). Attachment has been correlated
with virulence and pathogenicity (12, 35). M. pneumoniae
possesses a characteristic terminal tip-like structure (11, 20,
42) that is oriented in close juxtaposition to the infected
mucosal epithelium (14, 15, 24, 37). Previous studies have
indicated that specific attachment of M. pneumoniae to
target cells is mediated by the P1 adhesin protein (24) that is
located at the surface of the terminal tip organelle (23).
Treatment of virulent strain M-129-B16 with trypsin resulted
in loss of P1, a smaller protein (P2), and the ability to attach.
Regeneration of these proteins restored the ability of the
organism to attach (24) and indicates that the P1 protein is
the major surface component responsible for attachment (8,
23). Hu and colleagues (23, 27) have also shown that
monoclonal antibodies (MAbs) directed against the P1 pro-
tein can inhibit attachment, and these findings were con-
firmed by Gestenecker and Jacob (21). However, subsequent
studies have suggested that the molecular moiety of attach-
ment involves multiple components (18). Several investiga-
tors have suggested that components in addition to the P1
adhesin are probably involved in adherence (9, 10, 22, 27, 30,
31) and that accessory proteins are required for the attach-
ment process (8, 25, 29). Baseman et al. (8) showed that
noncytadsorbing mutant M129-B176 produces the P1 protein
but that P1 is not located at the terminal organelle. They also
reported that the 30-kDa protein (P30) is an adhesin, asso-
ciated with hemadsorption, that is localized at the terminal
tip structure of M. pneumoniae on the basis of biochemical,
immunological, and ultrastructural data (10). Stevens and
Krause (40) reported that the high-molecular-weight mem-
brane proteins associated with the cytoskeletonlike triton
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shell of M. pneumoniae are also localized primarily in the
filamentous extension of the mycoplasma cell on the basis of
biochemical and electron microscopy studies. They also
discussed their function in cytadherence. The evidence
suggested that the attachment element is an organized moi-
ety composed of a number of organized protein components.
This possibility is strongly supported by molecular cloning
and sequence analysis studies of the P1 operon (27, 28, 41).
These studies indicate that the P1 protein gene is part of an
operon that consists of three open reading frames (ORF) in
the order ORF4-P1-ORF6. Since analysis of the deduced
amino acid sequence indicates that both the P1 gene and
ORF6 possesses a membrane protein, a leader signal, and a
stop-transfer sequence (28), it is likely that both are compo-
nents of the attachment moeity. Recently, Sperker et al. (39)
demonstrated that instead of an expected 130-kDa protein,
90- and 40-kDa proteins were identified as the gene products
of ORF6. This indicates that the attachment moiety of M.
pneumoniae has a complex organization.
The P1 protein has been established as an important
disease-related immunogen (26). Antibodies specific for P1
were demonstrated in the respiratory secretions and sera of
patients with culture-proven M. pneumoniae infections.
Recently, Franzoso et al. (19) demonstrated that two addi-
tional proteins with approximate molecular masses of 86 and
35 kDa were highly immunogenic in experimentally infected
chimpanzees (19a). In the present study, we showed that the
86- and 35-kDa surface proteins were identical to the 90- and
40-kDa proteins described earlier by Hu et al. (25). These
proteins were present in each of three cytadsorbing, patho-
genic strains examined but absent in noncytadsorbing strain
M129-B176. We showed that the 90-kDa protein is localized
at the terminal tip structure of the organism and that the
40-kDa protein may also be localized at the tip. These
findings suggest that these two immunogenic proteins are
also involved in the attachment process and play a role in the
pathogenesis of disease.
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TABLE 1. Characteristics of the chimpanzees used in this study
Identification Size of inoculum Vaccine used for



















a Ccu, color-changing unit.
b Chimpanzees were experimentally infected intratracheally with either 1 x
107 or 3 x 107 color-changing units of virulent strain PI-1428 of M. pneumo-
niae.
c Chimpanzees were immunized with either the OSU-1A formalin-inacti-
vated vaccine or the acellular vaccine in 2 doses by the intraperitoneal priming
and intratracheal booster immunization schedule or given sterile broth (pos-
itive control) twice with a 3-week interval and then challenged intratracheally
2 weeks later with 107 color-changing units of virulent strain PI-1428 of M.
pneumoniae. The two chimpanzees with prior infections (see footnote e) were
also rechallenged. The same immunization schedule protected hamsters
against a challenge (4).
d The two negative-control chimpanzees inadvertently became infected
during the course of the study.
e Previously infected.
f Sterile broth was administered (see footnotes).
MATERIALS AND METHODS
M. pneumoniae. The three cytadsorbing pathogenic strains
used include low-passage, pathogenic, cytadsorbing strain
PI-1428, obtained from R. M. Chanock; strain M129, from
A. M. Collier; and strain FH, used in our previous study (3).
Noncytadsorbing, nonpathogenic derivative strain M129-
B176, passage 186 of strain M129 (36), was a gift from W. A.
Clyde, Jr. The mycoplasmas were grown in 150-cm2 Coming
flasks containing Edward-Hayflick medium (2) at 36 ± PC
for 5 to 7 days. The adherent colonies were scraped off into
the medium, and the cells were harvested following centrif-
ugation at 12,000 x g for 30 min at 4°C. The cell pellet was
washed twice in phosphate-buffered saline (PBS) pH 7.2,
aliquoted in 20 vials, and stored at -40°C until used.
Chimpanzees. The infected and immunized chimpanzees
used in these studies were used in earlier studies (7, 19). The
experimental protocol used is summarized in Table 1.
Chimpanzee sera. The sera used were also examined in
earlier studies (5, 6, 19). In this study, the immunoblot
patterns obtained with cytadsorbing, pathogenic strains PI-
1428, M129, and FH were compared with the patterns
obtained with noncytadsorbing, nonpathogenic, high-pas-
sage strain M129-B176. The paired preimmune and conva-
lescent-phase sera examined were obtained from five
groups, which included (i) six chimpanzees experimentally
infected with virulent strain M. pneumoniae PI-1428; (ii) two
negative control chimpanzee, 902 and 1061, that became
inadvertently infected; (iii) six chimpanzees immunized with
either a formalin-inactivated (chimpanzees 810, 903, and
1009) or an acellular (chimpanzees 905, 918, and 1008)
vaccine and challenged; (vi) two previously infected chim-
panzees (881 and 854) that were rechallenged; and (v) two
nonimmunized chimpanzees that were challenged and
served as positive controls. The convalescent-phase serum
of chimpanzee 957 was used in surface proteolysis studies,
and convalescent-phase sera from chimpanzees 902, 903,
1008, and 1009 were used in adsorption studies with aviru-
lent strain M129-B176 and/or horse serum.
Human sera. Paired acute and convalescent-phase sera of
a patient infected with M. pneumoniae were kindly supplied
by George Kenny, Seattle, Wash. The diagnosis of infection
was based on a fourfold rise in the titer of a specific antibody
to M. pneumoniae and direct isolation of the pathogen.
MAbs. Production of MAb M-328, directed against an
epitope(s) on the 169-kDa P1 adhesin protein, and MAbs
M-337 and M-384, directed against the 90- and 40-kDa
proteins, respectively, was described previously (23, 25).
Ascites were produced in BALB/c mice by intraperitoneal
injection of soft-agar-cloned hybridomas.
SDS-PAGE and immunoblot analyses. The polypeptide
patterns were examined by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) with 10 or 12%
nongradient or 10 to 20% gradient gels, as described by
Laemmli (34). Each lane was loaded with approximately 30
p,g of total protein. The proteins were transferred to nitro-
cellulose membranes (BA85; Schleicher & Schuell, Inc.,
Keene, N.H.) at 140 mA for 4 h at 4°C. The nitrocellulose
blots were incubated with agitation for 3 to 4 h in a blocking
solution (50 mM Tris-HCI [pH 7.4], 150 mM NaCl, 5 mM
EDTA, 0.25% Bloom gelatin, 0.05% Nonidet P-40, 2% horse
serum, 0.01% sodium azide). They were then incubated
overnight with a 1:100 dilution of serum or MAb in the
blocking solution. Blots were rinsed three times, for 20 min
each time, with the blocking solution and incubated for 4 h
with either the 125I-labeled or alkaline phosphatase-conju-
gated immunoglobulin G (IgG) fraction of anti-human or
anti-mouse immunoglobulins. Blots exposed to 125I-labeled
IgG were rinsed once with blocking solution and three times
with PBS. They were then air dried and exposed to film
(Kodak X-Omat AR diagnostic film). Blots in which the
alkaline phosphatase-conjugated secondary antibodies were
used were developed with nitroblue tetrazolium-5-bromo-4-
chloro-3-indolylphosphate toluidinium (salt) substrate from
Protoblot Immunoscreening Systems in accordance with the
manufacturer's (Promega, Madison, Wis.) recommenda-
tions. Goat anti-human IgG (Organon Teknika-Cappel Cor-
poration) was labeled with "1I as described previously C26)
and served as the second antibody. Anti-mouse IgG 1 5I-
labeled secondary antibody was obtained from Amersham,
Arlington Heights, Ill.
Adsorption with the avirulent strain. Strain M129-B176
was grown in 500 ml of broth medium (2), harvested follow-
ing centrifugation, and processed as described earlier (19).
The cell pellet was washed twice in PBS, and the cells
suspended in three ml of PBS were dispersed by three
passages through a 25-gauge needle. A 500-,ul aliquot of a
1:10 dilution of convalescent-phase chimpanzee serum was
mixed with 50 ,ul of the mycoplasma cells (approximately 107
CFU) and agitated gently at room temperature for 1 h. The
cells were sedimented by centrifugation in an Eppendorf
Microfuge (15,000 x g) for 20 min at 4°C, and the superna-
tant (adsorbed serum) was used in immunoblot assays
against strain PI-1428.
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Adsorption with horse serum. The horse serum used in the
broth medium was heated at 70°C for 5 to 10 min in an
Eppendorf tube. After cooling to room temperature, 50 ,u of
the heated horse serum was mixed with 500 RI of a 1:10
dilution of convalescent-phase chimpanzee serum and the
mixture was incubated at room temperature for 1 h. Partic-
ulate material was sedimented in an Eppendorf Microfuge at
15,000 x g for 10 min at 4°C, and the supernatant (adsorbed
serum) was used in immunoblot assays. These studies were
done to eliminate antibodies, if any, directed against the
horse serum component of the medium.
Surface proteolysis. A modification of the method reported
by Barbour and coworkers (1) was used. A broth culture of
pathogenic strain PI-1428 was sedimented by centrifugation,
and the pellet was washed twice in 0.25 M NaCl. The cells
were suspended by three passages through a 25-gauge nee-
dle, and the final protein concentration was adjusted to 100
or 500 ,ug/ml. Trypsin or proteinase K (Boehringer Mann-
heim, Indianapolis, Ind.) was added to 1.0 ml of the cell
suspension to a final concentration of 100 or 50 ,g/ml,
respectively, and the mixture was incubated, with occa-
sional shaking, for 30 to 60 min at either room temperature or
37°C. Trypsin proteolysis was terminated by adding 5 ,I of a
saturated solution (20 mg/ml) of phenylmethylsulfonyl fluo-
ride in isopropanol to a final concentration of 100 ,ug/ml.
Proteinase K proteolysis was terminated by addition of 20 ,u
of a 500 mM solution of EDTA to a final concentration of 10
mM. The cells were harvested following sedimentation at
15,000 x g at 4°C and washed four times with 0.25 mM NaCl
containing 50 ,ug of PMSF per ml, and the pellet was stored
at -40°C until used in the immunoblot assays.
Electron microscopy. To determine whether the 40- and
90-kDa proteins were localized on the surface of M. pneu-
moniae, organisms immunostained with MAbs were exam-
ined by electron microscopy as described previously (24,
25). Briefly, M. pneumoniae grown on glass coverslips in a
24-well microtiter plate was fixed with 2.0 ml of 0.5%
glutaraldehyde in PBS for 10 min. The specimen was washed
three times with PBS and incubated overnight at 4°C with
PBS containing 5% IgG-free horse serum (PBS-AHS). The
coverslips were incubated with 1.0 ml of MAb M-337 or
M-384 (heat-inactivated ascites diluted 1:20 in PBS-AHS) for
2 h at 37°C. After being washed three times with PBS-AHS,
the coverslips were incubated overnight at 4°C with 1.0 ml of
gold-conjugated goat anti-mouse IgG (Amersham Interna-
tional) diluted 1:10 in PBS-AHS. The coverslips were
washed three times with PBS-AHS, and the antibodies
adsorbed onto the organisms were fixed overnight with a
solution of 2% glutaraldehyde and 2% paraformaldehyde in
0.1 M phosphate buffer (pH 7.2) containing 6.8% sucrose.
The specimens were subjected to secondary fixation with 1%
osmium tetroxide in phosphate buffer for 1 h at room
temperature. Following dehydration, the samples were em-
bedded in Luff's Epon 812 and thin sections were cut with an
LKB Huxley ultramicrotome. The preparations were stained
with 5% uranyl acetate, followed by Reynolds lead citrate,
and sections were examined with a Zeiss EM-900 electron
microscope at an accelerating voltage of 50 kV.
RESULTS
MAbs. MAbs M-337 (anti-90 kDa) and M-384 (anti-40 kDa)
recognized the 86- and 35-kDa polypeptides, respectively, of
pathogenic strain PI-1428 that were also recognized by the
convalescent-phase sera of infected chimpanzee 902 at 8


























FIG. 1. When MAbs M-337 (anti-90-kDa protein) and M-384
(anti-40-kDa protein) were used for immunoblot analyses, strong
reactions with the 86- and 35-kDa polypeptides of pathogenic strain
PI-1428 were observed, indicating that the 90- and 40-kDa proteins
of Hu et al. (25) are very similar or identical to our 86- and 35-kDa
polypeptides. The pre- and postchallenge sera of chimpanzees 902
(at 8 weeks postchallenge) and 903 (at 16 weeks postchallenge)
recognized the 169-, 90-, and 40-kDa proteins following challenge.
The human acute and convalescent-phase sera used are described in
Materials and Methods. Conv, convalescent phase; SR, standard
reagent.
panzee 903 at 16 weeks postchallenge (Fig. 1). The 86- and
35-kDa proteins identified in the present study produced an
intense cross-reaction with MAbs specific to the 90- and
40-kDa proteins reported by Hu et al. (25) and Sperker et al.
(39), indicating that the 86- and 35-kDa proteins in our
studies (5, 6) are probably the same as the 90- and 40-kDa
proteins. Hu et al. (25) also reported that the 90- and 40-kDa
proteins were present in pathogenic strain M129 but absent
in its nonpathogenic, high-passage derivative M129-B176.
Our studies have confirmed and extended these findings. The
data presented in this report indicate that the 90-kDa protein
(shown as 86 kDa in Fig. 2A) and the 40-kDa protein (shown
as 35 kDa in Fig. 2B) were also present in two additional
pathogenic strains, PI-1428 and FH. The findings also indi-
cate that the 90- and 40-kDa polypeptides are conserved in
pathogenic strains but not in the avirulent strain. The non-
pathogenic strain does make the P1 protein, but it is not
localized at the terminal attachment tip of the organism (8),
indicating that the 90- and 40-kDa proteins are probably
required for anchorage and tip localization of the attachment
moiety.
Convalescent-phase chimpanzee sera. Convalescent-phase
serum of representative chimpanzee 903 (at 10 weeks
postchallenge) recognized the 90-kDa protein band (shown
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FIG. 2. Immunoblot analyses with MAbs M-337 (directed
against the 90-kDa protein but seen as an 86-kDa band [A]) and
M-384 (directed against the 40-kDa protein but seen as a 35-kDa
band [B]) showed that the 90- and 40-kDa proteins were present in
whole-cell preparations of pathogenic strains M129, PI-1428, and
FH of M. pneumoniae but absent in a whole-cell preparation of
noncytadsorbing, nonpathogenic, high-passage derivate M129-
B176.
pathogenic strains PI-1428, M129, and FH but not in non-
pathogenic strain M129-B176 (Fig. 3). The difference in the
immunoblot patterns of chimpanzee 903 in Fig. 1 and 3 is
attributable to the use of different serum bleeds. Identical
results were obtained with the convalescent-phase sera of
the other seven experimentally infected animals (data not
shown), and the findings indicate that these two proteins are
highly immunogenic. Nonetheless, no detectable differences
were observed in the protein profiles of the pathogenic and
nonpathogenic strains when SDS-PAGE with Coomassie
blue or silver staining was used (data not shown). This is
presumably due to the limited resolution of the one-dimen-
sional SDS-PAGE gels. Similar findings were described in
the earlier report of Hu et al. (25).
Immunoblot analyses revealed a weak 16-kDa band in the
pathogenic strains and not in the nonpathogenic strain, but
the identity or function of this protein is unknown.
Adsorption with the avirulent strain. The convalescent-
phase sera of chimpanzees 902 (which became infected), 903
(which was immunized with the OSU-1A vaccine and chal-
lenged), and 1008 (which was immunized with acellular
vaccine and challenged) were each adsorbed with whole-cell
pellets of avirulent strain M129-B176. Following adsorption,
the sera were examined by immunoblot analyses against
pathogenic strains PI-1428 and M129 and avirulent strain
M129-B176. The findings were similar for the three sera, and
typical results for representative chimpanzee 902 are shown
in Fig. 4. Adsorption completely removed the antibodies
reactive with the P1 adhesin band, and it decreased reactiv-
ity with most, but not all, of the other bands. The notable
exceptions were the 90- and 40-kDa protein bands. These
proteins were not affected by adsorption with the avirulent
strain, providing further evidence that these two proteins are
not expressed in the avirulent strain. Conversely, adsorption
with virulent strain PI-1428 completely inhibited reactivity
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FIG. 3. In immunoblot analyses, convalescent-phase serum of
representative chimpanzee 903, at 10 weeks postchallenge, recog-
nized the 90- and 40-kDa bands in whole-cell preparations of
cytadsorbing, pathogenic strains PI-1428 and M129 but not in a
whole-cell preparation of noncytadsorbing, nonpathogenic strain
M129-B176. SR, standard reagent.
Adsorption of convalescent-phase chimpanzee sera with
horse serum did not affect the intensity of immunoblot
reactions (data not shown) but did reduce the amount of
background activity.
Identification of the 90- and 40-kDa proteins as surface
components in M. pneumoniae. When whole-cell pellets of
pathogenic strain PI-1428 were treated with either trypsin or
proteinase K at room temperature and then used in for
immunoblotting, the 90-kDa protein (shown as 86 kDa) was
digested by both of the enzymes within 30 min. The reaction
was accelerated when the digestion was carried out at 37°C.
Following treatment with either enzyme, MAb M-337 (anti-
90-kDa protein) reacted with an 80-kDa degradation product,
indicating that the epitope remains with the fragment follow-
ing proteolysis (Fig. 5A).
Whereas trypsin may have induced only minimal digestion
of the 40-kDa protein (shown as 35 kDa), proteinase K
completely digested the protein within 30 min at room
temperature. Following digestion with proteinase K, anti-40-
kDa protein MAb M-384 did not react with any band,
























FIG. 4. Adsorption of convalescent-phase serum of chimpanzees
902 (at 10 weeks postchallenge) with whole-cell pellets of avirulent
strain M129-B176, followed by immunoblotting, indicated that anti-
bodies corresponding to several proteins, including the P1 adhesin
band, were removed and the intensity of most, but not all, of the
bands was decreased. The notable exceptions were the 90- and
40-kDa protein bands, indicating that the avirulent strain does not
express these two proteins.
Proteolysis with proteinase K, followed by immunoblot-
ting with convalescent-phase chimpanzee sera, indicated
that the patterns of the 169-, 90-, and 40-kDa proteins were
altered. Trypsin altered the patterns of the 169- and 90-kDa
proteins. These findings indicate that each of these proteins
contains surface-exposed domains that were digested (data
not shown). The 169-kDa P1 adhesin was shown to be a
surface-exposed protein earlier by researchers at several
laboratories (23, 24, 40). The data presented herein indicate
that the 90- and 40-kDa proteins are also surface exposed.
The other bands affected by proteolysis were the 148-, 117-,
30-, and 29-kDa proteins (data not shown).
Electron microscopy of immunostained organisms. When
M. pneumoniae was incubated with MAb M-337 (specific for
the 90-kDa protein), followed by gold-conjugated goat anti-
body to mouse IgG, electron microscopy indicated that MAb
M-337 reacted with the tip structure ofM. pneumoniae (Fig.
6A). This experimental approach and the results presented
are similar to those of our previous study, in which MAbs
specific for P1 were used to demonstrate that this adhesin










FIG. 5. Following surface proteolysis with proteinase K (Prot.
K) and trypsin, MAb M-337 (anti-90-kDa protein [seen as an 86-kDa
band]) reacted with an 80-kDa band (A), indicating that the major
part of the 90-kDa protein of pathogenic strain PI-1428 was not
exposed and thus was either integrated or located in the inner leaflet
of the membrane. Following surface proteolysis with proteinase K,
but not with trypsin, MAb M-384 (anti-40-kDa protein [seen as a
35-kDa band]) detected no bands, affirming that the binding epitope
was cleaved.
M-384, specific for the 40-kDa protein, was used, we failed
to detect a positive signal. The inability of MAb M-384 to
stain the tip structure may be due to the inaccessibility of the
specific epitope to this MAb under the experimental condi-
tions employed. Although immunostaining was unable to
demonstrate an association, it seems reasonable to assume
that the 40-kDa protein may also be associated with the tip
structure of M. pneumoniae.
DISCUSSION
Two chemically distinct classes of molecules were shown
to be receptors for attachment of M. pneumoniae to target
tissues. They are the sialic acid-conjugated glycoproteins
(38) and sulfated glycolipids (33). Together, these receptors
account for 90% of the attachment to cell cultures. In
addition to the 169-kDa P1 adhesin, several other proteins
were identified with attachment of the organism to erythro-
cytes, including a 30-kDa protein (22, 30-32, 40). Therefore,
adherence ofM. pneumoniae to target tissues involves more
than one receptor-adhesin complex.
Avirulent strain M129-B176, derived from virulent strain
M129 (35) by continuous broth passages, lost the ability to
colonize respiratory tissues in animals (35); the ability to
produce histologic lesions, including ciliotoxicity and leuko-
cyte recruitment in hamsters (3, 4); and the ability to attach
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FIG. 6. Electron micrographs of thin sections of M. pneumoniae
incubated with MAb M-337 (A) or M-384 (B) and immunostained
with gold-conjugated rabbit anti-mouse IgG. In panel A, gold grains
are clustered only around the terminal tip of M. pneumoniae
organisms.
to cell cultures (13). The avirulent strain does contain the P1
adhesin protein (25), but immunoferritin staining showed
that unlike in the pathogenic strains, the P1 protein is not
localized on the terminal tip apparatus of the avirulent strain
(8). These data supported the hypothesis that accessory
proteins are missing in the avirulent strain (29, 31) and are
required for anchorage and localization of the P1 adhesin.
The most convincing evidence that additional proteins are
involved in the attachment process is based on cloning and
nucleotide sequence analysis of the P1 operon (27, 28).
These studies have shown that the P1-encoding gene is
flanked by two ORFs, designated ORF4 and ORF6. ORF4
and ORF6 have respective coding capacities for proteins of
28 and 130 kDa. Since genes that interact functionally are
often organized in operons, efforts were made by Sperker et
al. (39) to identify the gene products of ORF4 and ORF6.
They attempted to determine whether these products play a
role in the attachment process. Mouse antisera directed
against fusion proteins derived from the ORF6 sequence
reacted with two proteins with respective molecular masses
of 40 and 90 kDa rather than a single 130-kDa protein (39).
Although the molecular mechanism(s) by which the precur-
sor 130-kDa protein is cleaved to produce the 40- and 90-kDa
proteins remains unknown, these data demonstrate that the
40- and 90-kDa proteins are the gene products of ORF6. The
cleavage site has been recently identified at amino acid
position 455 (R) on the basis of sequencing of the N terminus
of the isolated 90-kDa protein (35). Sperker et al. (39) have
suggested that the 90- and 40-kDa proteins represent two
cotranslational cleavage fragments of the ORF6 gene prod-
uct. However, it is more likely that the gene product of
ORF6 is translated as a single precursor polypeptide because
only a single leader signal sequence can be predicted from
the deduced amino acid sequence (27). This feature suggests
that cleavage of the 130-kDa precursor into the 40- and
90-kDa proteins probably takes place after the precursor
protein is translocated across the membrane.
In the present study, we showed that the 90-kDa protein is
located on the terminal structure of M. pneumoniae, as
determined by immunoelectron microscopy using a specific
MAb. Although immunostaining using one MAb, M-384
(specific for the 40-kDa protein), failed to produce a positive
signal, it is possible that the specific epitope of the 40-kDa
protein was not accessible to MAb M-384 under the exper-
imental conditions employed. Further study is required to
demonstrate its migration to the tip structure. Nevertheless,
these findings suggest that the two gene products of ORF6
participate in the attachment process.
Experimentally induced M. pneumoniae pneumonia in
chimpanzees was shown to be remarkably similar to natu-
rally occurring primary atypical pneumonia in patients (4b,
5). Chimpanzees immunized with either a formalin-inacti-
vated or an acellular vaccine were partially protected from
colonization and disease on challenge (4a, 19). After using
immunoblot analyses, we reported that the 90- and 40-kDa
proteins were major immunodominant components in the
convalescent-phase sera of (i) 10 experimentally infected
chimpanzees, (ii) 8 immunized chimpanzees given either an
acellular or a formalin-inactivated vaccine and then chal-
lenge with virulent strain PI-1428, and (iii) a patient with
naturally occurring, primary, atypical pneumonia (19, 19a).
The convalescent-phase chimpanzee sera also recognized
the P1 adhesin protein in avirulent strain M129-B176 (19).
Because the avirulent strain possesses the P1 adhesin pro-
tein but has poor attachment activity (13), factors other than
the 169-kDa adhesin protein are probably involved in the
attachment process.
The present study has shown that the 90- and 40-kDa
proteins identified previously by Hu et al. (25) were probably
identical to the 86- and 35-kDa proteins reported by us (19,
19a). These two proteins were present in each of the three
cytadsorbing, pathogenic strains examined but absent in
noncytadsorbing, nonpathogenic strain M129-B176. These
findings indicate that the 90- and 40-kDa proteins are highly
conserved among cytadsorbing, pathogenic strains. The
absence of these two proteins in noncytadsorbing, nonpatho-
genic strain M129-B176 was supported by the adsorption
studies with convalescent-phase chimpanzee sera. In addi-
tion, antibodies specific to the 90- and 40-kDa proteins were
removed by the whole organisms of pathogenic strains in the
absorption studies, suggesting that these proteins are located
on the cell surface. Recently, Yayoshi et al. (43) reported
that sera of patients produced intense reactions with 168-
and 85-kDa proteins of virulent strains of M. pneumoniae
but not with those of avirulent strains.
Surface proteolysis studies provided additional evidence
that the 90- and 40-kDa proteins were surface-exposed
membrane components. Lack of complete proteolytic diges-
tion suggests that these components are probably integral
membrane proteins, because following treatment with pro-
teinase K, MAb M-384 (specific for the 40-kDa protein)
detected no protein bands. Either this protein was com-
pletely digested or the antibody-binding site was destroyed
by digestion. On the other hand, the 40-kDa protein was
digested by proteinase K but was resistant to trypsin. This
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indicates that the arginine or lysine groups of the protein
were not accessible to trypsin.
In summary, we have shown that the immunodominant 86-
and 35-kDa proteins of M. pneumoniae described by Fran-
zoso et al. (19) are identical to the 90- and 40-kDa proteins of
M. pneumoniae described previously by Hu et al. (25) and
Sperker et al. (39). They are present in pathogenic, cytad-
sorbing strains PI-1428, M129, and FH but absent in non-
pathogenic, noncytadsorbing strain M129-B176. We have
also reported that these two proteins are immunodominant
components that were recognized by 18 convalescent-phase
sera of either experimentally infected or immunized chim-
panzees challenged with M. pneumoniae. The demonstra-
tion of these two components as surface-exposed membrane
proteins was supported by adsorption studies, surface pro-
teolysis, and electron microscopy in combination with im-
munostaining. The localization of the 90-kDa protein at the
terminal tip apparatus suggests that it is an essential compo-
nent involved in anchorage of P1 to the tip structure. These
findings also suggest that the 90- and 40-kDa proteins en-
coded by ORF6 of the P1 operon are among the accessory
proteins required, along with P1, for M. pneumoniae to
adhere to the respiratory epithelium.
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